Contributions
Stay tuned—this is where the team’s scientific contributions will be shared.
Accolades
Check back soon to see how this team is being recognized.
In the News
Endolysosomal Pathways in Parkinson’s Disease: Highlights from the 2025 Cell Biology of Parkinson’s Disease Conference
06/16/2026 — Read highlights from the 2025 Cell Biology of Parkinson’s Disease Conference that brought together investigators and trainees to discuss the intricacies of Parkinson’s disease at the cellular level.
MRC PPU researchers receive major funding to explore new frontiers in Parkinson’s disease
05/05/2026 — Researchers at the MRC Protein Phosphorylation and Ubiquitylation Unit (MRC PPU) at the University of Dundee have been awarded a series of major international research grants totalling $18 million from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with The Michael J. Fox Foundation for Parkinson's Research (MJFF).
Team Pfeffer Funded by Aligning Science Across Parkinson’s
05/04/2026 — Suzanne Pfeffer’s collaborative team has been selected to join the Collaborative Research Network (CRN), powered by the Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation. Together, this network is working to map the biological blueprint of Parkinson’s disease and accelerate the path to new treatments.
MJFF and ASAP Invest $261M in Global Network for Parkinson’s Research
04/30/2026 — Parkinson’s News Today reports that ASAP and The Michael J. Fox Foundation are investing $261 million to expand the Collaborative Research Network (CRN) to better understand what drives Parkinson’s disease and to accelerate the development of more personalized therapies.
Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments
04/28/2026 — Today, Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.
